Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02091245 |
Title | Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute |
Indications | |
Therapies | |
Age Groups: | child |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCSF | San Francisco | California | 94143 | United States | Details | |
Children's Hospital Colorado | Aurora | Colorado | 80045 | United States | Details | |
Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | United States | Details | |
Boston Children's Hospital | Boston | Massachusetts | 02115 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Texas Children's Hospital | Houston | Texas | 77030 | United States | Details | |
Seattle Children's Hospital | Seattle | Washington | 98101 | United States | Details | |
Children's Hospital of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |